Megan was selected for NIDAs DP1 Avenir Program to study genetic and epigenetic targets in addiction. Congratulations!
/wp-content/themes/awp-enfold/blank.png00Academic Web Pages/wp-content/themes/awp-enfold/blank.pngAcademic Web Pages2020-06-10 00:00:002020-06-10 00:00:00Megan was selected for NIDAs DP1 Avenir Program to study genetic and epigenetic targets in addiction. Congratulations!
